ウイルス保存溶液のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Virus Preservation Solution Market Insights, Forecast to 2028

• レポートコード：QY2207E10251 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のウイルス保存溶液の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にウイルス保存溶液の世界市場のxxx％を占める「不活性化ウイルス輸送液」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のウイルス保存溶液の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのウイルス保存溶液市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのウイルス保存溶液市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ウイルス保存溶液のグローバル主要メーカーには、Thermo Fisher Scientific、Longhorn Vaccines and Diagnostics、EKF Diagnostics Holdings、Mylab、Rapid Test Methods Ltd.、CellTreat、Labnet、Foxx Life Sciences、Heathrow Scientific、Motic Microscopy、VistaLab、Memmert、VH Bio Limited、Babio Corp、Improve Medical Instruments、Beyotimeなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ウイルス保存溶液市場は、種類と用途によって区分されます。世界のウイルス保存溶液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 不活性化ウイルス輸送液、非活性化ウイルス輸送液 【用途別セグメント】 病院、診療所、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ウイルス保存溶液製品概要 - 種類別市場（不活性化ウイルス輸送液、非活性化ウイルス輸送液） - 用途別市場（病院、診療所、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のウイルス保存溶液販売量予測2017-2028 - 世界のウイルス保存溶液売上予測2017-2028 - ウイルス保存溶液の地域別販売量 - ウイルス保存溶液の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ウイルス保存溶液販売量 - 主要メーカー別ウイルス保存溶液売上 - 主要メーカー別ウイルス保存溶液価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（不活性化ウイルス輸送液、非活性化ウイルス輸送液） - ウイルス保存溶液の種類別販売量 - ウイルス保存溶液の種類別売上 - ウイルス保存溶液の種類別価格 ・用途別市場規模（病院、診療所、その他） - ウイルス保存溶液の用途別販売量 - ウイルス保存溶液の用途別売上 - ウイルス保存溶液の用途別価格 ・北米市場 - 北米のウイルス保存溶液市場規模（種類別、用途別） - 主要国別のウイルス保存溶液市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのウイルス保存溶液市場規模（種類別、用途別） - 主要国別のウイルス保存溶液市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のウイルス保存溶液市場規模（種類別、用途別） - 主要国別のウイルス保存溶液市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のウイルス保存溶液市場規模（種類別、用途別） - 主要国別のウイルス保存溶液市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのウイルス保存溶液市場規模（種類別、用途別） - 主要国別のウイルス保存溶液市場規模（トルコ、サウジアラビア） ・企業情報 Thermo Fisher Scientific、Longhorn Vaccines and Diagnostics、EKF Diagnostics Holdings、Mylab、Rapid Test Methods Ltd.、CellTreat、Labnet、Foxx Life Sciences、Heathrow Scientific、Motic Microscopy、VistaLab、Memmert、VH Bio Limited、Babio Corp、Improve Medical Instruments、Beyotime ・産業チェーン及び販売チャネル分析 - ウイルス保存溶液の産業チェーン分析 - ウイルス保存溶液の原材料 - ウイルス保存溶液の生産プロセス - ウイルス保存溶液の販売及びマーケティング - ウイルス保存溶液の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ウイルス保存溶液の産業動向 - ウイルス保存溶液のマーケットドライバー - ウイルス保存溶液の課題 - ウイルス保存溶液の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Virus Preservation Solution Market
Due to the COVID-19 pandemic, the global Virus Preservation Solution market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Inactivated Virus Transport Medium accounting for % of the Virus Preservation Solution global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Virus Preservation Solution market size is valued at US$ million in 2021, while the US and Europe Virus Preservation Solution are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Virus Preservation Solution landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Virus Preservation Solution include Thermo Fisher Scientific, Longhorn Vaccines and Diagnostics, EKF Diagnostics Holdings, Mylab, Rapid Test Methods Ltd., CellTreat, Labnet, Foxx Life Sciences and Heathrow Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Virus Preservation Solution Scope and Segment
Virus Preservation Solution market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Virus Preservation Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Inactivated Virus Transport Medium
Non-Inactivated Virus Transport Medium
Segment by Application
Hospital
Clinic
Other
By Company
Thermo Fisher Scientific
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Mylab
Rapid Test Methods Ltd.
CellTreat
Labnet
Foxx Life Sciences
Heathrow Scientific
Motic Microscopy
VistaLab
Memmert
VH Bio Limited
Babio Corp
Improve Medical Instruments
Beyotime
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Virus Preservation Solution Product Introduction
1.2 Market by Type
1.2.1 Global Virus Preservation Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Virus Transport Medium
1.2.3 Non-Inactivated Virus Transport Medium
1.3 Market by Application
1.3.1 Global Virus Preservation Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Virus Preservation Solution Sales Estimates and Forecasts 2017-2028
2.2 Global Virus Preservation Solution Revenue Estimates and Forecasts 2017-2028
2.3 Global Virus Preservation Solution Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Virus Preservation Solution Sales by Region
2.4.1 Global Virus Preservation Solution Sales by Region (2017-2022)
2.4.2 Global Sales Virus Preservation Solution by Region (2023-2028)
2.5 Global Virus Preservation Solution Revenue by Region
2.5.1 Global Virus Preservation Solution Revenue by Region (2017-2022)
2.5.2 Global Virus Preservation Solution Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Virus Preservation Solution Sales by Manufacturers
3.1.1 Global Top Virus Preservation Solution Manufacturers by Sales (2017-2022)
3.1.2 Global Virus Preservation Solution Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Virus Preservation Solution in 2021
3.2 Global Virus Preservation Solution Revenue by Manufacturers
3.2.1 Global Virus Preservation Solution Revenue by Manufacturers (2017-2022)
3.2.2 Global Virus Preservation Solution Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Virus Preservation Solution Revenue in 2021
3.3 Global Virus Preservation Solution Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Virus Preservation Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Virus Preservation Solution Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Virus Preservation Solution Sales by Type
4.1.1 Global Virus Preservation Solution Historical Sales by Type (2017-2022)
4.1.2 Global Virus Preservation Solution Forecasted Sales by Type (2023-2028)
4.1.3 Global Virus Preservation Solution Sales Market Share by Type (2017-2028)
4.2 Global Virus Preservation Solution Revenue by Type
4.2.1 Global Virus Preservation Solution Historical Revenue by Type (2017-2022)
4.2.2 Global Virus Preservation Solution Forecasted Revenue by Type (2023-2028)
4.2.3 Global Virus Preservation Solution Revenue Market Share by Type (2017-2028)
4.3 Global Virus Preservation Solution Price by Type
4.3.1 Global Virus Preservation Solution Price by Type (2017-2022)
4.3.2 Global Virus Preservation Solution Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Virus Preservation Solution Sales by Application
5.1.1 Global Virus Preservation Solution Historical Sales by Application (2017-2022)
5.1.2 Global Virus Preservation Solution Forecasted Sales by Application (2023-2028)
5.1.3 Global Virus Preservation Solution Sales Market Share by Application (2017-2028)
5.2 Global Virus Preservation Solution Revenue by Application
5.2.1 Global Virus Preservation Solution Historical Revenue by Application (2017-2022)
5.2.2 Global Virus Preservation Solution Forecasted Revenue by Application (2023-2028)
5.2.3 Global Virus Preservation Solution Revenue Market Share by Application (2017-2028)
5.3 Global Virus Preservation Solution Price by Application
5.3.1 Global Virus Preservation Solution Price by Application (2017-2022)
5.3.2 Global Virus Preservation Solution Price Forecast by Application (2023-2028)
6 North America
6.1 North America Virus Preservation Solution Market Size by Type
6.1.1 North America Virus Preservation Solution Sales by Type (2017-2028)
6.1.2 North America Virus Preservation Solution Revenue by Type (2017-2028)
6.2 North America Virus Preservation Solution Market Size by Application
6.2.1 North America Virus Preservation Solution Sales by Application (2017-2028)
6.2.2 North America Virus Preservation Solution Revenue by Application (2017-2028)
6.3 North America Virus Preservation Solution Market Size by Country
6.3.1 North America Virus Preservation Solution Sales by Country (2017-2028)
6.3.2 North America Virus Preservation Solution Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Virus Preservation Solution Market Size by Type
7.1.1 Europe Virus Preservation Solution Sales by Type (2017-2028)
7.1.2 Europe Virus Preservation Solution Revenue by Type (2017-2028)
7.2 Europe Virus Preservation Solution Market Size by Application
7.2.1 Europe Virus Preservation Solution Sales by Application (2017-2028)
7.2.2 Europe Virus Preservation Solution Revenue by Application (2017-2028)
7.3 Europe Virus Preservation Solution Market Size by Country
7.3.1 Europe Virus Preservation Solution Sales by Country (2017-2028)
7.3.2 Europe Virus Preservation Solution Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Virus Preservation Solution Market Size by Type
8.1.1 Asia Pacific Virus Preservation Solution Sales by Type (2017-2028)
8.1.2 Asia Pacific Virus Preservation Solution Revenue by Type (2017-2028)
8.2 Asia Pacific Virus Preservation Solution Market Size by Application
8.2.1 Asia Pacific Virus Preservation Solution Sales by Application (2017-2028)
8.2.2 Asia Pacific Virus Preservation Solution Revenue by Application (2017-2028)
8.3 Asia Pacific Virus Preservation Solution Market Size by Region
8.3.1 Asia Pacific Virus Preservation Solution Sales by Region (2017-2028)
8.3.2 Asia Pacific Virus Preservation Solution Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Virus Preservation Solution Market Size by Type
9.1.1 Latin America Virus Preservation Solution Sales by Type (2017-2028)
9.1.2 Latin America Virus Preservation Solution Revenue by Type (2017-2028)
9.2 Latin America Virus Preservation Solution Market Size by Application
9.2.1 Latin America Virus Preservation Solution Sales by Application (2017-2028)
9.2.2 Latin America Virus Preservation Solution Revenue by Application (2017-2028)
9.3 Latin America Virus Preservation Solution Market Size by Country
9.3.1 Latin America Virus Preservation Solution Sales by Country (2017-2028)
9.3.2 Latin America Virus Preservation Solution Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Virus Preservation Solution Market Size by Type
10.1.1 Middle East and Africa Virus Preservation Solution Sales by Type (2017-2028)
10.1.2 Middle East and Africa Virus Preservation Solution Revenue by Type (2017-2028)
10.2 Middle East and Africa Virus Preservation Solution Market Size by Application
10.2.1 Middle East and Africa Virus Preservation Solution Sales by Application (2017-2028)
10.2.2 Middle East and Africa Virus Preservation Solution Revenue by Application (2017-2028)
10.3 Middle East and Africa Virus Preservation Solution Market Size by Country
10.3.1 Middle East and Africa Virus Preservation Solution Sales by Country (2017-2028)
10.3.2 Middle East and Africa Virus Preservation Solution Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Overview
11.1.3 Thermo Fisher Scientific Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Thermo Fisher Scientific Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Scientific Recent Developments
11.2 Longhorn Vaccines and Diagnostics
11.2.1 Longhorn Vaccines and Diagnostics Corporation Information
11.2.2 Longhorn Vaccines and Diagnostics Overview
11.2.3 Longhorn Vaccines and Diagnostics Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Longhorn Vaccines and Diagnostics Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Longhorn Vaccines and Diagnostics Recent Developments
11.3 EKF Diagnostics Holdings
11.3.1 EKF Diagnostics Holdings Corporation Information
11.3.2 EKF Diagnostics Holdings Overview
11.3.3 EKF Diagnostics Holdings Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 EKF Diagnostics Holdings Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 EKF Diagnostics Holdings Recent Developments
11.4 Mylab
11.4.1 Mylab Corporation Information
11.4.2 Mylab Overview
11.4.3 Mylab Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Mylab Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylab Recent Developments
11.5 Rapid Test Methods Ltd.
11.5.1 Rapid Test Methods Ltd. Corporation Information
11.5.2 Rapid Test Methods Ltd. Overview
11.5.3 Rapid Test Methods Ltd. Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Rapid Test Methods Ltd. Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Rapid Test Methods Ltd. Recent Developments
11.6 CellTreat
11.6.1 CellTreat Corporation Information
11.6.2 CellTreat Overview
11.6.3 CellTreat Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CellTreat Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CellTreat Recent Developments
11.7 Labnet
11.7.1 Labnet Corporation Information
11.7.2 Labnet Overview
11.7.3 Labnet Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Labnet Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Labnet Recent Developments
11.8 Foxx Life Sciences
11.8.1 Foxx Life Sciences Corporation Information
11.8.2 Foxx Life Sciences Overview
11.8.3 Foxx Life Sciences Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Foxx Life Sciences Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Foxx Life Sciences Recent Developments
11.9 Heathrow Scientific
11.9.1 Heathrow Scientific Corporation Information
11.9.2 Heathrow Scientific Overview
11.9.3 Heathrow Scientific Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Heathrow Scientific Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Heathrow Scientific Recent Developments
11.10 Motic Microscopy
11.10.1 Motic Microscopy Corporation Information
11.10.2 Motic Microscopy Overview
11.10.3 Motic Microscopy Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Motic Microscopy Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Motic Microscopy Recent Developments
11.11 VistaLab
11.11.1 VistaLab Corporation Information
11.11.2 VistaLab Overview
11.11.3 VistaLab Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 VistaLab Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 VistaLab Recent Developments
11.12 Memmert
11.12.1 Memmert Corporation Information
11.12.2 Memmert Overview
11.12.3 Memmert Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Memmert Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Memmert Recent Developments
11.13 VH Bio Limited
11.13.1 VH Bio Limited Corporation Information
11.13.2 VH Bio Limited Overview
11.13.3 VH Bio Limited Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 VH Bio Limited Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 VH Bio Limited Recent Developments
11.14 Babio Corp
11.14.1 Babio Corp Corporation Information
11.14.2 Babio Corp Overview
11.14.3 Babio Corp Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Babio Corp Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Babio Corp Recent Developments
11.15 Improve Medical Instruments
11.15.1 Improve Medical Instruments Corporation Information
11.15.2 Improve Medical Instruments Overview
11.15.3 Improve Medical Instruments Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Improve Medical Instruments Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Improve Medical Instruments Recent Developments
11.16 Beyotime
11.16.1 Beyotime Corporation Information
11.16.2 Beyotime Overview
11.16.3 Beyotime Virus Preservation Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Beyotime Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Beyotime Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Virus Preservation Solution Industry Chain Analysis
12.2 Virus Preservation Solution Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Virus Preservation Solution Production Mode & Process
12.4 Virus Preservation Solution Sales and Marketing
12.4.1 Virus Preservation Solution Sales Channels
12.4.2 Virus Preservation Solution Distributors
12.5 Virus Preservation Solution Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Virus Preservation Solution Industry Trends
13.2 Virus Preservation Solution Market Drivers
13.3 Virus Preservation Solution Market Challenges
13.4 Virus Preservation Solution Market Restraints
14 Key Findings in The Global Virus Preservation Solution Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Virus Preservation Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Inactivated Virus Transport Medium
Table 3. Major Manufacturers of Non-Inactivated Virus Transport Medium
Table 4. Global Virus Preservation Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Virus Preservation Solution Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Virus Preservation Solution Sales by Region (2017-2022) & (K Units)
Table 7. Global Virus Preservation Solution Sales Market Share by Region (2017-2022)
Table 8. Global Virus Preservation Solution Sales by Region (2023-2028) & (K Units)
Table 9. Global Virus Preservation Solution Sales Market Share by Region (2023-2028)
Table 10. Global Virus Preservation Solution Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Virus Preservation Solution Revenue Market Share by Region (2017-2022)
Table 12. Global Virus Preservation Solution Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Virus Preservation Solution Revenue Market Share by Region (2023-2028)
Table 14. Global Virus Preservation Solution Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Virus Preservation Solution Sales Share by Manufacturers (2017-2022)
Table 16. Global Virus Preservation Solution Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Virus Preservation Solution Revenue Share by Manufacturers (2017-2022)
Table 18. Virus Preservation Solution Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Virus Preservation Solution Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Virus Preservation Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Virus Preservation Solution as of 2021)
Table 21. Virus Preservation Solution Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Virus Preservation Solution Product Offered
Table 23. Date of Manufacturers Enter into Virus Preservation Solution Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Virus Preservation Solution Sales by Type (2017-2022) & (K Units)
Table 26. Global Virus Preservation Solution Sales by Type (2023-2028) & (K Units)
Table 27. Global Virus Preservation Solution Sales Share by Type (2017-2022)
Table 28. Global Virus Preservation Solution Sales Share by Type (2023-2028)
Table 29. Global Virus Preservation Solution Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Virus Preservation Solution Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Virus Preservation Solution Revenue Share by Type (2017-2022)
Table 32. Global Virus Preservation Solution Revenue Share by Type (2023-2028)
Table 33. Virus Preservation Solution Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Virus Preservation Solution Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Virus Preservation Solution Sales by Application (2017-2022) & (K Units)
Table 36. Global Virus Preservation Solution Sales by Application (2023-2028) & (K Units)
Table 37. Global Virus Preservation Solution Sales Share by Application (2017-2022)
Table 38. Global Virus Preservation Solution Sales Share by Application (2023-2028)
Table 39. Global Virus Preservation Solution Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Virus Preservation Solution Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Virus Preservation Solution Revenue Share by Application (2017-2022)
Table 42. Global Virus Preservation Solution Revenue Share by Application (2023-2028)
Table 43. Virus Preservation Solution Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Virus Preservation Solution Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Virus Preservation Solution Sales by Type (2017-2022) & (K Units)
Table 46. North America Virus Preservation Solution Sales by Type (2023-2028) & (K Units)
Table 47. North America Virus Preservation Solution Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Virus Preservation Solution Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Virus Preservation Solution Sales by Application (2017-2022) & (K Units)
Table 50. North America Virus Preservation Solution Sales by Application (2023-2028) & (K Units)
Table 51. North America Virus Preservation Solution Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Virus Preservation Solution Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Virus Preservation Solution Sales by Country (2017-2022) & (K Units)
Table 54. North America Virus Preservation Solution Sales by Country (2023-2028) & (K Units)
Table 55. North America Virus Preservation Solution Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Virus Preservation Solution Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Virus Preservation Solution Sales by Type (2017-2022) & (K Units)
Table 58. Europe Virus Preservation Solution Sales by Type (2023-2028) & (K Units)
Table 59. Europe Virus Preservation Solution Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Virus Preservation Solution Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Virus Preservation Solution Sales by Application (2017-2022) & (K Units)
Table 62. Europe Virus Preservation Solution Sales by Application (2023-2028) & (K Units)
Table 63. Europe Virus Preservation Solution Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Virus Preservation Solution Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Virus Preservation Solution Sales by Country (2017-2022) & (K Units)
Table 66. Europe Virus Preservation Solution Sales by Country (2023-2028) & (K Units)
Table 67. Europe Virus Preservation Solution Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Virus Preservation Solution Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Virus Preservation Solution Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Virus Preservation Solution Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Virus Preservation Solution Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Virus Preservation Solution Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Virus Preservation Solution Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Virus Preservation Solution Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Virus Preservation Solution Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Virus Preservation Solution Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Virus Preservation Solution Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Virus Preservation Solution Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Virus Preservation Solution Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Virus Preservation Solution Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Virus Preservation Solution Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Virus Preservation Solution Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Virus Preservation Solution Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Virus Preservation Solution Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Virus Preservation Solution Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Virus Preservation Solution Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Virus Preservation Solution Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Virus Preservation Solution Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Virus Preservation Solution Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Virus Preservation Solution Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Virus Preservation Solution Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Virus Preservation Solution Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Virus Preservation Solution Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Virus Preservation Solution Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Virus Preservation Solution Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Virus Preservation Solution Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Virus Preservation Solution Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Virus Preservation Solution Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Virus Preservation Solution Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Virus Preservation Solution Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Virus Preservation Solution Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Virus Preservation Solution Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Virus Preservation Solution Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Virus Preservation Solution Revenue by Country (2023-2028) & (US$ Million)
Table 105. Thermo Fisher Scientific Corporation Information
Table 106. Thermo Fisher Scientific Description and Major Businesses
Table 107. Thermo Fisher Scientific Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Thermo Fisher Scientific Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Thermo Fisher Scientific Recent Developments
Table 110. Longhorn Vaccines and Diagnostics Corporation Information
Table 111. Longhorn Vaccines and Diagnostics Description and Major Businesses
Table 112. Longhorn Vaccines and Diagnostics Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Longhorn Vaccines and Diagnostics Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Longhorn Vaccines and Diagnostics Recent Developments
Table 115. EKF Diagnostics Holdings Corporation Information
Table 116. EKF Diagnostics Holdings Description and Major Businesses
Table 117. EKF Diagnostics Holdings Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. EKF Diagnostics Holdings Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. EKF Diagnostics Holdings Recent Developments
Table 120. Mylab Corporation Information
Table 121. Mylab Description and Major Businesses
Table 122. Mylab Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Mylab Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Mylab Recent Developments
Table 125. Rapid Test Methods Ltd. Corporation Information
Table 126. Rapid Test Methods Ltd. Description and Major Businesses
Table 127. Rapid Test Methods Ltd. Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Rapid Test Methods Ltd. Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Rapid Test Methods Ltd. Recent Developments
Table 130. CellTreat Corporation Information
Table 131. CellTreat Description and Major Businesses
Table 132. CellTreat Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. CellTreat Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. CellTreat Recent Developments
Table 135. Labnet Corporation Information
Table 136. Labnet Description and Major Businesses
Table 137. Labnet Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Labnet Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Labnet Recent Developments
Table 140. Foxx Life Sciences Corporation Information
Table 141. Foxx Life Sciences Description and Major Businesses
Table 142. Foxx Life Sciences Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Foxx Life Sciences Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Foxx Life Sciences Recent Developments
Table 145. Heathrow Scientific Corporation Information
Table 146. Heathrow Scientific Description and Major Businesses
Table 147. Heathrow Scientific Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Heathrow Scientific Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Heathrow Scientific Recent Developments
Table 150. Motic Microscopy Corporation Information
Table 151. Motic Microscopy Description and Major Businesses
Table 152. Motic Microscopy Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. Motic Microscopy Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Motic Microscopy Recent Developments
Table 155. VistaLab Corporation Information
Table 156. VistaLab Description and Major Businesses
Table 157. VistaLab Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. VistaLab Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. VistaLab Recent Developments
Table 160. Memmert Corporation Information
Table 161. Memmert Description and Major Businesses
Table 162. Memmert Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Memmert Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Memmert Recent Developments
Table 165. VH Bio Limited Corporation Information
Table 166. VH Bio Limited Description and Major Businesses
Table 167. VH Bio Limited Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. VH Bio Limited Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. VH Bio Limited Recent Developments
Table 170. Babio Corp Corporation Information
Table 171. Babio Corp Description and Major Businesses
Table 172. Babio Corp Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 173. Babio Corp Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Babio Corp Recent Developments
Table 175. Improve Medical Instruments Corporation Information
Table 176. Improve Medical Instruments Description and Major Businesses
Table 177. Improve Medical Instruments Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 178. Improve Medical Instruments Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Improve Medical Instruments Recent Developments
Table 180. Beyotime Corporation Information
Table 181. Beyotime Description and Major Businesses
Table 182. Beyotime Virus Preservation Solution Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 183. Beyotime Virus Preservation Solution Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Beyotime Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Virus Preservation Solution Distributors List
Table 188. Virus Preservation Solution Customers List
Table 189. Virus Preservation Solution Market Trends
Table 190. Virus Preservation Solution Market Drivers
Table 191. Virus Preservation Solution Market Challenges
Table 192. Virus Preservation Solution Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Virus Preservation Solution Product Picture
Figure 3. Global Virus Preservation Solution Market Share by Type in 2021 & 2028
Figure 3. Inactivated Virus Transport Medium Product Picture
Figure 4. Non-Inactivated Virus Transport Medium Product Picture
Figure 5. Global Virus Preservation Solution Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Virus Preservation Solution Report Years Considered
Figure 10. Global Virus Preservation Solution Sales 2017-2028 (K Units)
Figure 11. Global Virus Preservation Solution Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Virus Preservation Solution Revenue 2017-2028 (US$ Million)
Figure 13. Global Virus Preservation Solution Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Virus Preservation Solution Sales Market Share by Region (2017-2022)
Figure 15. Global Virus Preservation Solution Sales Market Share by Region (2023-2028)
Figure 16. North America Virus Preservation Solution Sales YoY (2017-2028) & (K Units)
Figure 17. North America Virus Preservation Solution Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Virus Preservation Solution Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Virus Preservation Solution Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Virus Preservation Solution Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Virus Preservation Solution Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Virus Preservation Solution Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Virus Preservation Solution Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Virus Preservation Solution Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Virus Preservation Solution Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Virus Preservation Solution Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Virus Preservation Solution in the World: Market Share by Virus Preservation Solution Revenue in 2021
Figure 28. Global Virus Preservation Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Virus Preservation Solution Sales Market Share by Type (2017-2028)
Figure 30. Global Virus Preservation Solution Revenue Market Share by Type (2017-2028)
Figure 31. Global Virus Preservation Solution Sales Market Share by Application (2017-2028)
Figure 32. Global Virus Preservation Solution Revenue Market Share by Application (2017-2028)
Figure 33. North America Virus Preservation Solution Sales Market Share by Type (2017-2028)
Figure 34. North America Virus Preservation Solution Revenue Market Share by Type (2017-2028)
Figure 35. North America Virus Preservation Solution Sales Market Share by Application (2017-2028)
Figure 36. North America Virus Preservation Solution Revenue Market Share by Application (2017-2028)
Figure 37. North America Virus Preservation Solution Sales Share by Country (2017-2028)
Figure 38. North America Virus Preservation Solution Revenue Share by Country (2017-2028)
Figure 39. United States Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Virus Preservation Solution Sales Market Share by Type (2017-2028)
Figure 42. Europe Virus Preservation Solution Revenue Market Share by Type (2017-2028)
Figure 43. Europe Virus Preservation Solution Sales Market Share by Application (2017-2028)
Figure 44. Europe Virus Preservation Solution Revenue Market Share by Application (2017-2028)
Figure 45. Europe Virus Preservation Solution Sales Share by Country (2017-2028)
Figure 46. Europe Virus Preservation Solution Revenue Share by Country (2017-2028)
Figure 47. Germany Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 48. France Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Virus Preservation Solution Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Virus Preservation Solution Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Virus Preservation Solution Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Virus Preservation Solution Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Virus Preservation Solution Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Virus Preservation Solution Revenue Share by Region (2017-2028)
Figure 58. China Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 61. India Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Virus Preservation Solution Sales Market Share by Type (2017-2028)
Figure 68. Latin America Virus Preservation Solution Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Virus Preservation Solution Sales Market Share by Application (2017-2028)
Figure 70. Latin America Virus Preservation Solution Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Virus Preservation Solution Sales Share by Country (2017-2028)
Figure 72. Latin America Virus Preservation Solution Revenue Share by Country (2017-2028)
Figure 73. Mexico Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Virus Preservation Solution Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Virus Preservation Solution Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Virus Preservation Solution Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Virus Preservation Solution Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Virus Preservation Solution Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Virus Preservation Solution Revenue Share by Country (2017-2028)
Figure 83. Turkey Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Virus Preservation Solution Revenue (2017-2028) & (US$ Million)
Figure 86. Virus Preservation Solution Value Chain
Figure 87. Virus Preservation Solution Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---